IL17A and fungal infectious disease: Throughout the OLE, the majority of fungal infections were mild-to-moderate, mucocutaneous Candida infections, such as oral candidiasis, likely due to the role of IL-17 in mucosal host defences against fungal infections (particularly those caused by Candida) [34, 35].